Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: Time series analysis

BMJ (Online)

Volumn 339, Issue 7718, 2009, Pages 435-437

  Hawton, Keith ^a   Bergen, Helen ^a   Simkin, Sue ^a   Brock, Anita ^b   Griffiths, Clare ^b   Romeri, Ester ^b   Smith, Karen L ^a   Kapur, Navneet ^c   Gunnell, David ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCODAMOL; CODEINE; CODYDRAMOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIHYDROCODEINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TRAMADOL; ACETAMINOPHEN PROPOXYPHENE COMBINATION; ACETAMINOPHEN-PROPOXYPHENE COMBINATION; ANALGESIC AGENT; DEXTROPROPOXYPHENE; PRESCRIPTION DRUG;

ACCIDENTAL DEATH; ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG FATALITY; DRUG INTOXICATION; DRUG SAFETY; HEALTH STATISTICS; PRESCRIPTION; PRIORITY JOURNAL; SUICIDE; TIME SERIES ANALYSIS; UNITED KINGDOM; DRUG APPROVAL; DRUG COMBINATION; HUMAN; INTOXICATION; LEGAL ASPECT; MORTALITY; STATISTICS;

ACETAMINOPHEN; ANALGESICS; DEXTROPROPOXYPHENE; DRUG APPROVAL; DRUG COMBINATIONS; ENGLAND; HUMANS; MORTALITY; POISONING; PRESCRIPTION DRUGS; SUICIDE; WALES;

EID: 69449102410     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2270     Document Type: Article

References (26)

1. Simkin S, Hawton K, Sutton L, Gunnell D, Bennewith O, Kapur N. Coproxamol and suicide: a review to inform initiatives to prevent the continuing toll of overdose deaths. Q J Med 2005;98:159-170
2. Hawton K, Simkin S, Deeks JJ. Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self-poisonings. BMJ 2003;326:1006-1008 (Pubitemid 36566857)
3. Drug and Therapeutics Bulletin. Distalgesic and its equivalents: time for action. DTB 1983;21:17-19
4. Bateman DN, Afshari R. Licence needs to be changed. BMJ 2003;327:287.
5. Hawton K, Simkin S, Gunnell D, Sutton L, Bennewith O, Turnbull P, et al. A multicentre study of co-proxamol poisoning suicides based on coroners' records in England. Br J Clin Pharmacol 2005;59:207-212 (Pubitemid 40208857)
6. Office for National Statistics. Deaths related to drug poisoning: England and Wales, 1993-2005. Health Statistics Q 2007;33:82-88
7. Medicines and Healthcare products Regulatory Agency. Withdrawal of co-proxamol products and interim updated prescribing information CEM/CMO/2005/2. www.mhra.gov.uk/home/groups/ pl-a/documents/websiteresources/con019461.pdf.
8. Committee on Safety of Medicines. Withdrawal of co-proxamol (Distalgesic, Cosalgesic, Dolgesic). Curr Probl Pharmacovigilance 2006;31:11.
9. The Information Centre for Health and Social Care PSU. Prescription Cost Analysis: England 2005. Leeds: Department of Health, 2006.
10. The Information Centre for health and social care PSU. Prescription Cost Analysis: England 2006. Leeds: Department of Health, 2007.
11. Sandilands EA, Bateman DN. Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol 2008;66:290-293
12. Hawton K, Harriss L, Zahl D. Deaths from all causes in a long-term follow-up study of 11,583 deliberate self harmpatients. Psychol Med 2006;36:397-405.
13. Daigle MS. Suicide prevention through means restriction: assessing the risk of substitution: a critical review and synthesis. Accid Anal Prev 2005;37:625-632
14. Adelstein A, Mardon C. Suicides 1961-1974. Popul Trends 1975;2:13-18
15. Brock A, Baker A, Griffiths C, Jackson G, Fegan G, Marshall D. Suicide trends and geographical variations in the United Kingdom, 1991-2004. Health Statistics Q 2006;31:6-22.
16. Stata Corporation. Stata Statistical Software: Release 10. College Station, TX: Stata Corporation, 2007.
17. Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 2003;19:613-623 (Pubitemid 38405635)
18. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309. (Pubitemid 34989269)
19. Office for National Statistics. Deaths related to drug poisoning in England and Wales, 2003-2007. Health Statistics Q 2008;39:82-88
20. Jonasson U, Jonasson B. Restrictions on the prescribing of dextropropoxyphene (DXP) - effects on sales and cases of fatal poisoning. Report for the Swedish National Board of Forensic Medicine and Medical Products Agency. Last update 2004. www. rmv.se/pdf/dxp-report.pdf.
21. Segest E, Harris CN, Bay H. Dextropropoxyphene deaths in Denmark from the health authority point of view. Med Law 1993;12:141-151 (Pubitemid 23271576)
22. Hawton K. Restricting access to methods of suicide: Rationale and evaluation of this approach to suicide prevention. Crisis 2007;28(suppl 1):4-9.
23. Gottlieb S. Warnings issued over COX 2 inhibitors in US and UK. BMJ 2005;330:9.
24. Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, etal. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004;329:1076-1079
25. Finkle BS. Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience. Human Toxicol 1984;3:115-34S.
26. Zhang F, Wagner A, Soumerai SB, Ross-Degnan D. Estimating confidence intervals around relative changes in outcomes in segmented regression analyses of time series data. 15th Annual NESUG (NorthEast SAS Users Group Inc) Conference. Last update 2002. www.nesug.info/Proceedings/nesug02/st/st005.pdf.